Leukemogenesis as a new approach to investigate the correlation between up regulated gene 4/upregulator of cell proliferation (URG4/URGCP) and signal transduction genes in leukemia

[1]  Y. Dodurga,et al.  The expression of URGCP gene in prostate cancer cell lines: correlation with rapamycin , 2012, Molecular Biology Reports.

[2]  Y. Dodurga,et al.  RNA interference-mediated URG4 gene silencing diminishes cyclin D1 mRNA expression in HepG2 cells. , 2010, Genetics and molecular research : GMR.

[3]  Z. Darżynkiewicz,et al.  DNA damage response as a biomarker in treatment of leukemias , 2009, Cell cycle.

[4]  Yingmei Wang,et al.  The expression of novel gene URG4 in osteosarcoma: correlation with patients' prognosis , 2009, Pathology.

[5]  Yan Yu,et al.  [Detection of human cyclin C gene expression in childhood acute lymphocytic leukemia using real-time fluorescence quantitative PCR]. , 2008, Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics.

[6]  B. Johansson,et al.  Mutations of FLT3, NRAS, KRAS, and PTPN11 are frequent and possibly mutually exclusive in high hyperdiploid childhood acute lymphoblastic leukemia , 2008, Genes, chromosomes & cancer.

[7]  Christopher B. Miller,et al.  Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia , 2007, Nature.

[8]  P. Loyer,et al.  Two Isoforms of the Human Cyclin C Gene are Expressed Differentially Suggesting that they May Have Distinct Functions , 2007, Acta biologica Hungarica.

[9]  Haifeng Jin,et al.  Enhanced cell survival of gastric cancer cells by a novel gene URG4. , 2006, Neoplasia.

[10]  A. Yoshida,et al.  Highly frequent allelic loss of chromosome 6q16-23 in osteosarcoma: involvement of cyclin C in osteosarcoma. , 2006, International journal of molecular medicine.

[11]  Irving L Weissman,et al.  Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. , 2006, Cancer research.

[12]  S. Katsuma,et al.  Role of Chk1 and Chk2 in Ara‐C‐induced differentiation of human leukemia K562 cells , 2005, Genes to cells : devoted to molecular & cellular mechanisms.

[13]  Sergei Kozlov,et al.  ATM signaling and genomic stability in response to DNA damage. , 2005, Mutation research.

[14]  Heinz Baumann,et al.  Signal transducer and activator of transcription proteins in leukemias. , 2003, Blood.

[15]  B. Quesnel,et al.  p16INK4a immunocytochemical analysis is an independent prognostic factor in childhood acute lymphoblastic leukemia , 2002 .

[16]  B. Quesnel,et al.  Prognostic significance of p16INK4a immunocytochemistry in adult ALL with standard risk karyotype , 2001, Leukemia.

[17]  C. Pui,et al.  Biological and therapeutic aspects of infant leukemia. , 2000, Blood.

[18]  M. Diccianni,et al.  Universal inactivation of both p16 and p15 but not downstream components is an essential event in the pathogenesis of T-cell acute lymphoblastic leukemia. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[19]  Yoichi Taya,et al.  ATM associates with and phosphorylates p53: mapping the region of interaction , 1999, Nature Genetics.

[20]  Y. Shiloh,et al.  Interaction between ATM protein and c-Abl in response to DNA damage , 1997, Nature.

[21]  C. Sherr.  Cancer Cell Cycles , 1996, Science.

[22]  Joseph R. Nevins,et al.  The E2F transcription factor is a cellular target for the RB protein , 1991, Cell.

[23]  R. Weinberg,et al.  G1/S phosphorylation of the retinoblastoma protein is associated with an altered affinity for the nuclear compartment , 1991, Cell.

[24]  P. Arbuthnot,et al.  Hepatitis Bx antigen stimulates expression of a novel cellular gene, URG4, that promotes hepatocellular growth and survival. , 2002, Neoplasia.

[25]  Y. Shiloh,et al.  ATM: genome stability, neuronal development, and cancer cross paths. , 2001, Advances in cancer research.

[26]  H. Sather,et al.  leukemia predicts independent risk of relapse deletion in pediatric acute lymphoblastic INK4A p16 Hemizygous , 2010 .